• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

J&J Brings Ottava into the Forefront of Surgical Robotics with New IDE Approval

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 12, 2024 at 08:42: PM
via The New Brunswick, NJ-based company might have cleared a regulatory milestone, but it still faces steep competition in the surgical robotics market from Intuitive Surgical and Medtronic.

article source
 




Top Bottom
Back
Quote